the acorda therapeutics ( na ) therapeutics program is a new technology that is a powerful tool for the treatment of patients with Parkinson's disease. it is a novel and effective drug that is a highly effective and safe drug for the treatment of patients with Parkinson 'd disease. we report the first quarter of our research and its success in the last year. we are awaiting the development of a new drug for the treatment of symptoms of OFF periods and people with Parkinson's disease who are taking carbidopa/levodopa regimen. we are awaiting the development of generics and we will now open up the call to questions about the launch of this new drug.